secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001171843-22-003330
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp. Q1 revenue $22.4M (+28% YoY); net loss $206K; adj. EBITDA $1.8M; updates guidance
--------------------------------------------------------------------------------

- Revenue $22.4M, up 28% YoY; system-wide sales $98.8M (+27%); comp sales +15%.
- Net loss $206K ($0.01/sh) vs net income $2.3M ($0.16 diluted) in Q1 2021.
- Adjusted EBITDA $1.8M, down from $3.5M; operating loss $176K vs profit $2.0M.
- Opened 31 clinics (27 franchised, 4 greenfield) – record Q1; total clinics 736.
- Guidance updated: FY rev $98-102M; adj. EBITDA $12-14M; 110-130 franchised openings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322003330/0001171843-22-003330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322003330/f8k_050522.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-003330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer